246 related articles for article (PubMed ID: 28082117)
1. Targeting endothelial metabolism for anti-angiogenesis therapy: A pharmacological perspective.
Missiaen R; Morales-Rodriguez F; Eelen G; Carmeliet P
Vascul Pharmacol; 2017 Mar; 90():8-18. PubMed ID: 28082117
[TBL] [Abstract][Full Text] [Related]
2. Angiogenesis revisited - role and therapeutic potential of targeting endothelial metabolism.
Stapor P; Wang X; Goveia J; Moens S; Carmeliet P
J Cell Sci; 2014 Oct; 127(Pt 20):4331-41. PubMed ID: 25179598
[TBL] [Abstract][Full Text] [Related]
3. Glycosylation as new pharmacological strategies for diseases associated with excessive angiogenesis.
Bousseau S; Vergori L; Soleti R; Lenaers G; Martinez MC; Andriantsitohaina R
Pharmacol Ther; 2018 Nov; 191():92-122. PubMed ID: 29909237
[TBL] [Abstract][Full Text] [Related]
4. Manipulating Angiogenesis by Targeting Endothelial Metabolism: Hitting the Engine Rather than the Drivers-A New Perspective?
Treps L; Conradi LC; Harjes U; Carmeliet P
Pharmacol Rev; 2016 Jul; 68(3):872-87. PubMed ID: 27363442
[TBL] [Abstract][Full Text] [Related]
5. The Link Between Angiogenesis and Endothelial Metabolism.
Potente M; Carmeliet P
Annu Rev Physiol; 2017 Feb; 79():43-66. PubMed ID: 27992732
[TBL] [Abstract][Full Text] [Related]
6. Angiogenesis revisited from a metabolic perspective: role and therapeutic implications of endothelial cell metabolism.
Draoui N; de Zeeuw P; Carmeliet P
Open Biol; 2017 Dec; 7(12):. PubMed ID: 29263247
[TBL] [Abstract][Full Text] [Related]
7. Angiogenic impairment of the vascular endothelium: a novel mechanism and potential therapeutic target in muscular dystrophy.
Palladino M; Gatto I; Neri V; Straino S; Smith RC; Silver M; Gaetani E; Marcantoni M; Giarretta I; Stigliano E; Capogrossi M; Hlatky L; Landolfi R; Pola R
Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2867-76. PubMed ID: 24072696
[TBL] [Abstract][Full Text] [Related]
8. Targeting fatty acid metabolism in cancer and endothelial cells.
Harjes U; Kalucka J; Carmeliet P
Crit Rev Oncol Hematol; 2016 Jan; 97():15-21. PubMed ID: 26558689
[TBL] [Abstract][Full Text] [Related]
9. Targeting endothelial cell metabolism in cancerous microenvironment: a new approach for anti-angiogenic therapy.
Mohammadi P; Yarani R; Rahimpour A; Ranjbarnejad F; Mendes Lopes de Melo J; Mansouri K
Drug Metab Rev; 2022 Nov; 54(4):386-400. PubMed ID: 36031813
[TBL] [Abstract][Full Text] [Related]
10. Dimethylarginine dimethylaminohydrolase: a new therapeutic target for the modulation of nitric oxide and angiogenesis.
Singh JP
Curr Opin Investig Drugs; 2007 Sep; 8(9):736-41. PubMed ID: 17729185
[TBL] [Abstract][Full Text] [Related]
11. Endothelial Cell Metabolism in Health and Disease.
Rohlenova K; Veys K; Miranda-Santos I; De Bock K; Carmeliet P
Trends Cell Biol; 2018 Mar; 28(3):224-236. PubMed ID: 29153487
[TBL] [Abstract][Full Text] [Related]
12. Reversal of cellular roles in angiogenesis: implications for anti-angiogenic therapy.
Virgintino D; Ozerdem U; Girolamo F; Roncali L; Stallcup WB; Perris R
J Vasc Res; 2008; 45(2):129-31. PubMed ID: 17943023
[No Abstract] [Full Text] [Related]
13. Cyclic adenosine monophosphate-response element-binding protein mediates the proangiogenic or proinflammatory activity of gremlin.
Corsini M; Moroni E; Ravelli C; Andrés G; Grillo E; Ali IH; Brazil DP; Presta M; Mitola S
Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):136-45. PubMed ID: 24233491
[TBL] [Abstract][Full Text] [Related]
14. Redox signaling in angiogenesis: role of NADPH oxidase.
Ushio-Fukai M
Cardiovasc Res; 2006 Jul; 71(2):226-35. PubMed ID: 16781692
[TBL] [Abstract][Full Text] [Related]
15. Anti-angiogenic properties of calcium trifluoroacetate.
Bussolati B; Ribatti D; Munaron L; Bartorelli A; Bussolati G
Microvasc Res; 2009 Dec; 78(3):272-7. PubMed ID: 19631669
[TBL] [Abstract][Full Text] [Related]
16. Angiogenesis Revisited: An Overlooked Role of Endothelial Cell Metabolism in Vessel Sprouting.
Vandekeere S; Dewerchin M; Carmeliet P
Microcirculation; 2015 Oct; 22(7):509-17. PubMed ID: 26250801
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase-2-selective nonsteroidal anti-inflammatory drugs inhibit hepatocyte growth factor/scatter factor-induced angiogenesis.
Sengupta S; Sellers LA; Cindrova T; Skepper J; Gherardi E; Sasisekharan R; Fan TP
Cancer Res; 2003 Dec; 63(23):8351-9. PubMed ID: 14678996
[TBL] [Abstract][Full Text] [Related]
18. Principles of targeting endothelial cell metabolism to treat angiogenesis and endothelial cell dysfunction in disease.
Goveia J; Stapor P; Carmeliet P
EMBO Mol Med; 2014 Sep; 6(9):1105-20. PubMed ID: 25063693
[TBL] [Abstract][Full Text] [Related]
19. Endothelial cell metabolism: an update anno 2017.
Teuwen LA; Draoui N; Dubois C; Carmeliet P
Curr Opin Hematol; 2017 May; 24(3):240-247. PubMed ID: 28212191
[TBL] [Abstract][Full Text] [Related]
20. Vascular Detransformation for Cancer Therapy.
Fan Y
Trends Cancer; 2019 Aug; 5(8):460-463. PubMed ID: 31421902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
